NOT-HL-23-111: Notice of Technical Assistance Webinar and FAQs for NOT-HL-23-113 (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established longitudinal studies (R01 CT Optional)

Notice of Technical Assistance Webinar and FAQs for NOT-HL-23-113 (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established longitudinal studies (R01 CT Optional)

Notice Number:

NOT-HL-23-111

Key Dates

Release Date:

September 15, 2023

Related Announcements

August 25, 2023 - Notice of Expiration of NOT-HL-23-102 "Notice of Special Interest (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established cohorts (R01 Clinical Trial Optional)." See NOT-HL-23-112.
August 25, 2023 - Notice of Special Interest (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established longitudinal studies (R01 Clinical Trial Optional), See NOT-HL-23-113.
August 9, 2023 - (EXPIRED) Notice of Special Interest (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established cohorts (R01 Clinical Trial Optional). See NOT-HL-23-102.
May 25, 2023 - Updated Notice of Information for HIV research priorities at the National Heart, Lung, and Blood Institute. See Notice NOT-HL-23-088.
May 10, 2022 - Dissemination and Implementation Research in Health (R01 Clinical Trial Optional). See NOFO PAR-22-105.

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The National Heart, Lung, and Blood Institute (NHLBI) reissued a Notice of Special Interest on August 25, 2023: NOT-HL-23-113 "Notice of Special Interest (NOSI) Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established longitudinal studies (R01 Clinical Trial Optional), directed at the Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) funding opportunity PAR-22-105. (Prior notice NOT-HL-23-102).

A pre-submission technical assistance webinar is being offered to inform potential applicants about NOT-HL-23-113. This will include a review of the purpose and objectives of the Notice.

All prospective applicants are invited to attend and are strongly encouraged to send relevant questions prior to the webinar to maximize the use of time. Questions should be sent by email to mary.masterson@nih.gov by Tuesday, October 17, 2023.

Participation in this webinar, although encouraged, is optional and is not required for the submission of applications in response to NOT-HL-23-113. The webinar will be recorded. Responses to questions will be posted on a Frequently Asked Questions (FAQs) page on the NHLBI Website soon thereafter; search for NOT-HL-23-113, or use the following link:

https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/NOT-HL-23-113.html

Session Date and Time:

Monday, October 23, 2023, at 2:00 pm EDT

https://nih.zoomgov.com/meeting/register/vJItf--pqjwrExfobQjbu1F3Q2qbOWZcQEo

Inquiries

Please direct all inquiries to:

Mary Masterson, PhD, MS
National Heart, Lung, and Blood Institute (NHLBI)
Center for Translation Research and Implementation Science (CTRIS)
Email: Mary.Masterson@nih.gov